Literature DB >> 26061241

Visualizing G Protein-Coupled Receptor-Receptor Interactions in Brain Using Proximity Ligation In Situ Assay.

Jaume Taura1, Víctor Fernández-Dueñas1, Francisco Ciruela1,2.   

Abstract

G protein-coupled receptors (GPCRs) constitute the largest family of plasma membrane receptors, thus representing the more investigated drug targets in the design of new therapeutic strategies. The existence of receptor-receptor interactions has revolutionized the field, since GPCR oligomerization might confer new intervention opportunities in pharmacotherapy. However, demonstrating the existence of such receptor-receptor interactions in native tissue has been a bottleneck in GPCR pharmacology. Here, we discuss an experimental approach, the proximity ligation in situ assay (P-LISA), which provides enough sensitivity to evaluate a receptor's close proximity within a named GPCR oligomer. Indeed, we provide a detailed step-by-step protocol for P-LISA experiments visualizing receptor-receptor interactions in brain slices. Additionally, we provide instructions for slide observation, data acquisition and quantification. Finally, we also discuss these critical aspects determining the success of the technique, namely the fixation process and the validation of the primary antibodies used. Overall, the P-LISA is a powerful and straightforward technique to visualize receptor-receptor interactions when performed under optimal conditions.
Copyright © 2015 John Wiley & Sons, Inc.

Keywords:  GPCR; brain; oligomerization; proximity ligation assay

Mesh:

Substances:

Year:  2015        PMID: 26061241     DOI: 10.1002/0471143030.cb1717s67

Source DB:  PubMed          Journal:  Curr Protoc Cell Biol        ISSN: 1934-2616


  11 in total

1.  Proximity Ligation Assay for Detecting Protein-Protein Interactions and Protein Modifications in Cells and Tissues in Situ.

Authors:  Marihan Hegazy; Eran Cohen-Barak; Jennifer L Koetsier; Nicole A Najor; Constadina Arvanitis; Eli Sprecher; Kathleen J Green; Lisa M Godsel
Journal:  Curr Protoc Cell Biol       Date:  2020-12

2.  Habit Formation after Random Interval Training Is Associated with Increased Adenosine A2A Receptor and Dopamine D2 Receptor Heterodimers in the Striatum.

Authors:  Yan He; Yan Li; Mozi Chen; Zhilan Pu; Feiyang Zhang; Long Chen; Yang Ruan; Xinran Pan; Chaoxiang He; Xingjun Chen; Zhihui Li; Jiang-Fan Chen
Journal:  Front Mol Neurosci       Date:  2016-12-26       Impact factor: 5.639

3.  The Parkinson's disease-associated GPR37 receptor interacts with striatal adenosine A2A receptor controlling its cell surface expression and function in vivo.

Authors:  Xavier Morató; Rafael Luján; Marc López-Cano; Jorge Gandía; Igor Stagljar; Masahiko Watanabe; Rodrigo A Cunha; Víctor Fernández-Dueñas; Francisco Ciruela
Journal:  Sci Rep       Date:  2017-08-25       Impact factor: 4.379

4.  Angiotensin II type 1/adenosine A 2A receptor oligomers: a novel target for tardive dyskinesia.

Authors:  Paulo A de Oliveira; James A R Dalton; Marc López-Cano; Adrià Ricarte; Xavier Morató; Filipe C Matheus; Andréia S Cunha; Christa E Müller; Reinaldo N Takahashi; Víctor Fernández-Dueñas; Jesús Giraldo; Rui D Prediger; Francisco Ciruela
Journal:  Sci Rep       Date:  2017-05-12       Impact factor: 4.379

5.  Singular Location and Signaling Profile of Adenosine A2A-Cannabinoid CB1 Receptor Heteromers in the Dorsal Striatum.

Authors:  Estefanía Moreno; Anna Chiarlone; Mireia Medrano; Mar Puigdellívol; Lucka Bibic; Lesley A Howell; Eva Resel; Nagore Puente; María J Casarejos; Juan Perucho; Joaquín Botta; Nuria Suelves; Francisco Ciruela; Silvia Ginés; Ismael Galve-Roperh; Vicent Casadó; Pedro Grandes; Beat Lutz; Krisztina Monory; Enric I Canela; Carmen Lluís; Peter J McCormick; Manuel Guzmán
Journal:  Neuropsychopharmacology       Date:  2017-01-19       Impact factor: 7.853

6.  Triglyceride Form of Docosahexaenoic Acid Mediates Neuroprotection in Experimental Parkinsonism.

Authors:  Maricel Gómez-Soler; Begoña Cordobilla; Xavier Morató; Víctor Fernández-Dueñas; Joan C Domingo; Francisco Ciruela
Journal:  Front Neurosci       Date:  2018-08-28       Impact factor: 4.677

7.  PBF509, an Adenosine A2A Receptor Antagonist With Efficacy in Rodent Models of Movement Disorders.

Authors:  Fabiana Núñez; Jaume Taura; Juan Camacho; Marc López-Cano; Víctor Fernández-Dueñas; Naomi Castro; Julio Castro; Francisco Ciruela
Journal:  Front Pharmacol       Date:  2018-10-19       Impact factor: 5.810

8.  Detecting G protein-coupled receptor complexes in postmortem human brain with proximity ligation assay and a Bayesian classifier.

Authors:  Ying Zhu; József Mészáros; Roman Walle; Rongxi Fan; Ziyi Sun; Andrew J Dwork; Pierre Trifilieff; Jonathan A Javitch
Journal:  Biotechniques       Date:  2019-12-20       Impact factor: 1.993

9.  Nanoscale alterations in GABAB receptors and GIRK channel organization on the hippocampus of APP/PS1 mice.

Authors:  Alejandro Martín-Belmonte; Carolina Aguado; Rocío Alfaro-Ruiz; Ana Esther Moreno-Martínez; Luis de la Ossa; Ester Aso; Laura Gómez-Acero; Ryuichi Shigemoto; Yugo Fukazawa; Francisco Ciruela; Rafael Luján
Journal:  Alzheimers Res Ther       Date:  2022-09-21       Impact factor: 8.823

10.  Serotonin Receptor 5-HT2A Regulates TrkB Receptor Function in Heteroreceptor Complexes.

Authors:  Tatiana Ilchibaeva; Anton Tsybko; Andre Zeug; Franziska E Müller; Daria Guseva; Stephan Bischoff; Evgeni Ponimaskin; Vladimir Naumenko
Journal:  Cells       Date:  2022-08-02       Impact factor: 7.666

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.